TY - JOUR
T1 - Association between 1,25-dihydroxyvitamin D and left atrial diameter in pre-dialysis chronic kidney disease patients
AU - Inaguma, Daijo
AU - Shinjo, Hibiki
AU - Tanaka, Akihito
AU - Ito, Eri
AU - Kamegai, Naoki
AU - Kato, Akiko
AU - Mizutani, Minami
AU - Shimogushi, Hiroya
AU - Otsuka, Yasuhiro
AU - Takeda, Asami
AU - Hasegawa, Midori
AU - Yuzawa, Yukio
N1 - Publisher Copyright:
©2016 Dustri-Verlag Dr. K. Feistle.
PY - 2016
Y1 - 2016
N2 - Objective: To investigate the correlation between serum 1,25-dihydroxyvitamin D (1,25D) levels and left atrial diameter (LAD) using echocardiography in pre-dialysis chronic kidney disease (CKD). Subjects and methods: From an initial population of 487 patients (109 met the exclusion criteria), a total of 378 patients with CKD stage 3a-5 who had not undergone dialysis or kidney transplantation were included in the study. The relationship between serum 1,25D levels and LAD was examined. Moreover, factors that impacted LAD were extracted through stepwise multiple regression analyses. Results: Serum 1,25D levels correlated negatively with LAD, left ventricular end-diastolic diameter, interventricular septum thickness, end-diastolic volume, stroke volume, left ventricular mass index (LVMI), and E/e'. Stepwise multiple regression analyses revealed there was a significant relationship between serum 1,25D levels and LAD (regression coefficient =-0.070, p = 0.001). In the stratified analysis, serum 1,25D levels were associated with LAD in the LVMI < 125 g/m2 (regression coefficient =-0.067, p = 0.038) and ejection fraction (EF) ≥ 60% groups (regression coefficient =-0.080, p = 0.004). Conclusion: Serum 1,25D levels were independently associated with LAD in CKD patients; however, the association was not significant in patients with an EF < 60% and LVMI > 125 g/m2.
AB - Objective: To investigate the correlation between serum 1,25-dihydroxyvitamin D (1,25D) levels and left atrial diameter (LAD) using echocardiography in pre-dialysis chronic kidney disease (CKD). Subjects and methods: From an initial population of 487 patients (109 met the exclusion criteria), a total of 378 patients with CKD stage 3a-5 who had not undergone dialysis or kidney transplantation were included in the study. The relationship between serum 1,25D levels and LAD was examined. Moreover, factors that impacted LAD were extracted through stepwise multiple regression analyses. Results: Serum 1,25D levels correlated negatively with LAD, left ventricular end-diastolic diameter, interventricular septum thickness, end-diastolic volume, stroke volume, left ventricular mass index (LVMI), and E/e'. Stepwise multiple regression analyses revealed there was a significant relationship between serum 1,25D levels and LAD (regression coefficient =-0.070, p = 0.001). In the stratified analysis, serum 1,25D levels were associated with LAD in the LVMI < 125 g/m2 (regression coefficient =-0.067, p = 0.038) and ejection fraction (EF) ≥ 60% groups (regression coefficient =-0.080, p = 0.004). Conclusion: Serum 1,25D levels were independently associated with LAD in CKD patients; however, the association was not significant in patients with an EF < 60% and LVMI > 125 g/m2.
UR - http://www.scopus.com/inward/record.url?scp=84995811840&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995811840&partnerID=8YFLogxK
U2 - 10.5414/CN108794
DO - 10.5414/CN108794
M3 - Article
C2 - 27730807
AN - SCOPUS:84995811840
SN - 0301-0430
VL - 86
SP - 229
EP - 235
JO - Clinical nephrology
JF - Clinical nephrology
IS - 5
ER -